BELLEVUE, Wash., Jan. 16, 2026 /PRNewswire/ -- Vaximm AG, a subsidiary of OSR Holdings, Inc. and a pioneer in oral T-cell immunotherapies for cancer, today announced the appointment of Sébastien Wieckowski, PhD, as Chief Scientific Officer (CSO). This appointment strategically strengthens...
Hence then, the article about vaximm appoints sebastien wieckowski phd as chief scientific officer to advance next generation oral immunotherapy platform was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Vaximm Appoints Sébastien Wieckowski, PhD, as Chief Scientific Officer to Advance Next-Generation Oral Immunotherapy Platform )
Also on site :
- 2000s Heavy Metal Band Shares Exciting Music Festival News
- Saudi to Sudan: Can Pakistan expand military footprint across Arab world?
- Large house fire near Buckeye Lake kills one, critically injures second victim